Beijing Foyou Pharma CO.(SH:601089) Xin Lang Cai Jing·2025-10-30 01:33Group 1 - The core point of the article is that Fuyuan Pharmaceutical (601089.SH) reported its Q3 2025 results, highlighting significant institutional ownership and changes in fund holdings [1] - As of October 29, 2025, a total of 8 institutional investors hold shares in Fuyuan Pharmaceutical, with a combined holding of 361 million shares, representing 75.30% of the total share capital [1] - The institutional ownership decreased by 0.16 percentage points compared to the previous quarter [1] Group 2 - In terms of public funds, 2 new public funds were disclosed this quarter, including E Fund Healthcare Industry Mixed A and Ping An New Xin Pioneer Mixed A [1] - A total of 72 public funds were not disclosed this quarter compared to the previous quarter, including several ETFs and mixed funds [1] - Regarding foreign investment, one foreign fund, Hong Kong Central Clearing Limited, reduced its holdings by 0.26% this quarter [2]